BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22995926)

  • 21. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
    Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
    Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients.
    Martín-Peña A; Aguilar-Guisado M; Espigado I; Parody R; Miguel Cisneros J
    Clin Transplant; 2011; 25(3):468-74. PubMed ID: 20482561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic stem-cell transplantation following solid-organ transplantation in children.
    Schechter T; Gassas A; Weitzman S; Grant D; Pollock-BarZiv S; Dipchand A; Alexander S; Ali M; Avitzur Y; Doyle J
    Bone Marrow Transplant; 2011 Oct; 46(10):1321-5. PubMed ID: 21822316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations.
    Youssef A; Hafez H; Madney Y; Elanany M; Hassanain O; Lehmann LE; El Haddad A
    Pediatr Transplant; 2020 Feb; 24(1):e13610. PubMed ID: 31682054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X; Liu D
    Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemia.
    Kim H; Lee KH; Sohn SK; Jung CW; Joo YD; Kim SH; Kim BS; Choi JH; Kwak JY; Kim MK; Bae SH; Shin HJ; Won JH; Oh S; Lee WS; Park JH; Yoon SS
    Leuk Res; 2013 Oct; 37(10):1241-7. PubMed ID: 23871157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation.
    Subbarao G; Haut PR; Johnson CS; Gowan D; Molleston JP
    Pediatr Transplant; 2006 Sep; 10(6):682-9. PubMed ID: 16911491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome.
    Mendes ET; Dulley F; Basso M; Batista MV; Coracin F; Guimarães T; Shikanai-Yasuda MA; Levin AS; Costa SF
    Int J Infect Dis; 2012 Jun; 16(6):e424-8. PubMed ID: 22463920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic hematopoietic stem cell transplant for adults over 40 years old with acquired aplastic anemia.
    Kim H; Lee KH; Yoon SS; Sohn SK; Joo YD; Kim SH; Kim BS; Choi JH; Kwak JY; Hyun MS; Bae SH; Shin HJ; Won JH; Oh S; Lee WS; Park JH; Jung CW;
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1500-8. PubMed ID: 22472480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in the immunoregulatory genes are associated with hematopoietic recovery and increased susceptibility to bacterial infections in patients with thalassaemia major undergoing matched related hematopoietic stem cell transplantation.
    Sellathamby S; Lakshmi KM; Busson M; Viswabandya A; George B; Mathews V; Chandy M; Charron D; Krishnamoorthy R; Tamouza R; Srivastava A
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1219-26. PubMed ID: 22252124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell regeneration in pediatric allogeneic stem cell transplantation.
    Olkinuora H; Talvensaari K; Kaartinen T; Siitonen S; Saarinen-Pihkala U; Partanen J; Vettenranta K
    Bone Marrow Transplant; 2007 Feb; 39(3):149-56. PubMed ID: 17211435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.
    Gjaerde LI; Moser C; Sengeløv H
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28561378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular complications in children within 1 year after hematopoietic stem cell transplantation.
    Kalinina Ayuso V; Hettinga Y; van der Does P; Boelens JJ; Rothova A; de Boer J
    JAMA Ophthalmol; 2013 Apr; 131(4):470-5. PubMed ID: 23450391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of late onset non-infectious pulmonary complications following pediatric allogeneic hematopoietic stem cell transplantation.
    Park M; Koh KN; Kim BE; Im HJ; Seo JJ
    Clin Transplant; 2011; 25(2):E168-76. PubMed ID: 21077955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lethal pulmonary complications after pediatric allogeneic hematopoietic stem cell transplantation.
    Fazekas T; Attarbaschi A; Lawitschka A; Seidel M; Pötschger U; Peters C; Mann G; Gadner H; Matthes-Martin S
    Pediatr Infect Dis J; 2012 Feb; 31(2):115-9. PubMed ID: 21909046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
    Mikulska M; Del Bono V; Raiola AM; Bruno B; Gualandi F; Occhini D; di Grazia C; Frassoni F; Bacigalupo A; Viscoli C
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-existing anti-HLA antibodies negatively impact survival of pediatric aplastic anemia patients undergoing HSCT.
    Zhu H; He J; Cai J; Yuan X; Jiang H; Luo C; Wang J; Luo C; Pan Z; Terasaki PI; Ding L; Chen J
    Clin Transplant; 2014 Nov; 28(11):1225-33. PubMed ID: 25123053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.